How we de-risked our SaaS pricing strategy?

Start with the real problem: medtech SaaS pricing is constrained by procurement, not your feature list

In medtech, “pricing strategy” fails most often because founders price like a generic B2B SaaS company. Hospitals and health systems don’t buy software the way startups do: budgets are siloed, approvals are multi-step, and the economic buyer (who signs) is often not the end user (who benefits). We de-risked our SaaS pricing strategy by treating pricing as a clinical workflow + procurement + ROI problem, then validating each assumption with lightweight experiments before committing to a price sheet.

We used a simple rule: no pricing decision is “real” until it survives a procurement conversation. That meant we validated (1) who pays, (2) what budget it comes from, (3) what approval thresholds apply, and (4) what measurable value we can credibly claim.

Step 1: Map the buyer chain and the budget line (before choosing a pricing metric)

We started by mapping three roles for each target customer type:

• User: clinician, nurse, tech, care coordinator, or lab staff who touches the product daily.
• Champion: department lead, service line director, quality/safety leader, or informatics manager who pushes the project internally.
• Economic buyer: VP/Director level (IT, operations, finance) or procurement who can approve spend.

Then we asked a set of “budget reality” questions in discovery calls (not in a pitch):

• Which budget would this come from: IT, department OPEX, quality, innovation, or a grant-funded program?
• Is this treated as software, a clinical system, or a “medical device software” purchase? (This affects review rigor.)
• What are the approval thresholds (e.g., manager approval vs committee review)? These vary by institution.
• Who owns security review, legal review, and vendor onboarding timelines?

This step de-risked pricing because it prevented us from choosing a pricing metric that procurement hates. For example, “per clinician seat” sounds SaaS-native, but many hospitals struggle to count seats and will push back. Conversely, “per facility” is easy to approve but can underprice high-volume sites unless you include tiers.

Step 2: Choose a pricing metric tied to value and procurement simplicity

We evaluated pricing metrics using two criteria: value alignment (does price scale with the value created?) and procurement simplicity (can the buyer understand and approve it quickly?). In medtech SaaS, the best metric is often the one that is easiest to buy, not the one that is theoretically perfect.

Common medtech SaaS pricing metrics (and when they work)

• Per facility / per site: easiest for procurement; good when value is broad and cross-department. Risk: underpricing large sites unless tiered.
• Per department / service line: good when adoption is localized (e.g., cardiology, radiology). Risk: expansion friction across departments.
• Per user (named or concurrent): works when usage is clearly attributable (e.g., specialist workflows). Risk: seat counting and “shadow users.”
• Per study / per case / per patient episode: strong value alignment for workflow tools; procurement can accept if volumes are predictable. Risk: forecasting disputes.
• Outcome- or savings-based: compelling story, but hard to contract and measure; often better as an add-on or renewal lever than a first contract.

We intentionally avoided complex usage-based pricing early. Hospitals want predictability. We aimed for a metric that could be explained in one sentence and fit into an annual budget cycle.

Step 3: De-risk willingness-to-pay with “price discovery” experiments (without burning trust)

Instead of asking “What would you pay?” (which yields unreliable answers), we ran structured price discovery using three tactics:

1. Anchored ranges in late-stage discovery: after confirming the workflow pain and buyer, we tested a range: “We typically see solutions like this land in the low five-figures to low six-figures per year depending on scope. Which side of that feels realistic for your environment?” This reveals budget class without forcing a single number.
2. Package testing: we presented 2–3 packages with clear scope boundaries (not feature soup). Example: “Core (single department), Plus (multi-department), Enterprise (system-wide + integrations).” The goal was to learn what they’d trade off to hit a budget.
3. Procurement pre-check: we asked champions to introduce us to procurement/IT finance before a pilot. If procurement said “anything above X triggers committee,” we designed packaging to fit below or to justify crossing it.

Key principle: we treated these as collaborative design conversations, not negotiation. In clinical environments, trust is currency; you can’t “growth hack” pricing without damaging credibility.

Step 4: Use pilots to validate ROI claims and convert them into a pricing narrative

In medtech SaaS, pricing becomes easy when your ROI story is credible. We de-risked by designing pilots that produced procurement-friendly evidence, not just user enthusiasm.

Design a pilot that answers the buyer’s two questions

• Does it work here? (workflow fit, integration burden, adoption)
• Is it worth paying for? (time saved, throughput, reduced errors, reduced length of stay, avoided readmissions—whatever is relevant)

We defined 2–4 measurable pilot endpoints, such as:

• Minutes saved per case (validated by time-motion sampling or system logs)
• Reduction in rework, duplicate documentation, or order errors
• Throughput improvements (e.g., cases/day) where applicable
• Compliance/quality metrics when the buyer is quality/safety

Then we translated outcomes into a pricing narrative: “If we save X minutes per case and you do Y cases/month, that’s Z hours/month. Even if only a portion converts to capacity, the annual value is meaningfully above the subscription.” We avoided claiming universal savings; we framed it as “in your environment, during the pilot, we observed…”

If your product touches clinical research workflows, IRB approval may be relevant for data collection. We planned for that early so the pilot didn’t stall. If your product is regulated (Software as a Medical Device), FDA pathway (often 510(k) or De Novo depending on claims) affects timelines and what you can promise commercially—so we kept pricing tied to workflow value, not unapproved clinical claims.

Step 5: Build a pricing architecture that survives hospital procurement

We ended with a pricing structure that balanced simplicity and expansion:

• Base subscription (annual): tied to a procurement-friendly unit (often facility or department) with clear scope.
• Implementation fee (one-time): justified by integration, training, and project management. Many hospitals expect this line item.
• Integration tiering: EHR integration, SSO, HL7/FHIR interfaces, or data warehouse work can be priced as add-ons or higher tiers, because they create real cost and procurement understands them.
• Expansion triggers: clear rules for moving from single department to multi-department to enterprise, so growth doesn’t require renegotiating from scratch.

We also wrote down “pricing guardrails” for sales: minimum contract value, discount limits, and what concessions require founder approval. This prevented one-off deals from destroying the model.

Finally, we aligned pricing with reimbursement reality. If your value proposition depends on billing (e.g., remote monitoring, clinical decision support workflows), you must understand whether CPT codes exist, whether reimbursement is realistic for your customer type, and who captures that revenue (hospital vs physician group). If reimbursement is uncertain or varies widely, we avoided making it the primary justification for price.

What to do next

1. Run a buyer-chain interview sprint: 10 conversations split across users, champions, and economic buyers; document budget source, approval thresholds, and procurement blockers.
2. Pick one pricing metric that optimizes procurement simplicity (facility/department) and add tiering to protect upside.
3. Design a pilot with 2–4 measurable endpoints and a data collection plan (including IRB considerations if needed) so ROI is defensible.
4. Create a 3-package price card (Core/Plus/Enterprise) and test it in late-stage discovery with anchored ranges.
5. Write pricing guardrails: minimums, discount policy, and integration/implementation rules before you scale sales.

If you want a structured way to pressure-test your positioning and pricing logic, use our internal-style tools and templates.